Atlas Trials

Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis

Clinical trial NCT00630656 · COMPLETED

Trial details

NCT number
NCT00630656
Sponsor
Agennix
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Sepsis
Start date
2008-04-01
Primary completion
2009-08-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.